{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=4154174","PageTitle":"聚焦抗体药物创新，多个First in class产品未来可期-公司调研 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":80,"Face":"/_files/face/0/lcrdf5dl.jpg","UName":"杞思懿","UpArts":0,"UpRpts":24337,"UpLbies":28},"Rid":4154174,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/公司调研/20221218-安信证券-百利天恒-688506.SH-聚焦抗体药物创新多个Firstinclass产品未来可期.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}
微信公众号